| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antifungal Agents | 21 | 2025 | 290 | 1.660 |
Why?
|
| AIDS-Related Opportunistic Infections | 18 | 2010 | 130 | 1.590 |
Why?
|
| Amphotericin B | 13 | 2013 | 87 | 1.250 |
Why?
|
| Histoplasmosis | 14 | 2025 | 55 | 1.070 |
Why?
|
| Cryptococcosis | 12 | 2013 | 40 | 1.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 9 | 2009 | 261 | 1.000 |
Why?
|
| Meningitis, Cryptococcal | 5 | 2010 | 19 | 0.660 |
Why?
|
| Fluconazole | 11 | 2013 | 48 | 0.630 |
Why?
|
| Central Nervous System Fungal Infections | 2 | 2025 | 13 | 0.620 |
Why?
|
| Enterocolitis, Pseudomembranous | 5 | 2007 | 92 | 0.590 |
Why?
|
| Inflammation | 4 | 2015 | 1421 | 0.570 |
Why?
|
| Metronidazole | 4 | 2007 | 157 | 0.540 |
Why?
|
| Anti-Bacterial Agents | 14 | 2021 | 2502 | 0.510 |
Why?
|
| Staphylococcus aureus | 10 | 2008 | 467 | 0.500 |
Why?
|
| Mycoses | 3 | 2013 | 102 | 0.500 |
Why?
|
| Cryptococcus neoformans | 6 | 2011 | 21 | 0.500 |
Why?
|
| Acquired Immunodeficiency Syndrome | 9 | 2007 | 219 | 0.480 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2015 | 18 | 0.470 |
Why?
|
| Internal Medicine | 2 | 2025 | 127 | 0.460 |
Why?
|
| Immunomodulation | 1 | 2015 | 78 | 0.460 |
Why?
|
| Lung Diseases, Fungal | 3 | 2008 | 37 | 0.440 |
Why?
|
| Methicillin Resistance | 6 | 2008 | 116 | 0.420 |
Why?
|
| HIV Infections | 12 | 2025 | 1948 | 0.410 |
Why?
|
| Scedosporium | 1 | 2013 | 6 | 0.400 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 288 | 0.390 |
Why?
|
| Cross Infection | 9 | 2006 | 333 | 0.390 |
Why?
|
| Fungi | 1 | 2013 | 58 | 0.390 |
Why?
|
| Cellulitis | 3 | 2011 | 59 | 0.360 |
Why?
|
| Deoxycholic Acid | 1 | 2010 | 14 | 0.330 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 215 | 0.330 |
Why?
|
| Thiazoles | 2 | 2007 | 103 | 0.310 |
Why?
|
| Staphylococcal Infections | 6 | 2006 | 556 | 0.300 |
Why?
|
| Community-Acquired Infections | 3 | 2006 | 249 | 0.300 |
Why?
|
| Blister | 1 | 2008 | 20 | 0.290 |
Why?
|
| Pneumonia | 3 | 2011 | 334 | 0.290 |
Why?
|
| Actinomycosis | 1 | 2008 | 8 | 0.280 |
Why?
|
| Humans | 103 | 2025 | 126518 | 0.280 |
Why?
|
| Histoplasma | 9 | 2025 | 37 | 0.270 |
Why?
|
| Hepatitis C | 1 | 2011 | 380 | 0.270 |
Why?
|
| Bronchoscopy | 1 | 2008 | 177 | 0.260 |
Why?
|
| Pulmonary Emphysema | 1 | 2008 | 91 | 0.260 |
Why?
|
| Mediastinum | 1 | 2006 | 47 | 0.250 |
Why?
|
| Internship and Residency | 2 | 2025 | 1201 | 0.250 |
Why?
|
| Middle Aged | 38 | 2025 | 27511 | 0.240 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2013 | 380 | 0.240 |
Why?
|
| Escherichia coli | 4 | 2013 | 962 | 0.230 |
Why?
|
| Fluoroquinolones | 3 | 2013 | 90 | 0.230 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 167 | 0.220 |
Why?
|
| HIV-1 | 3 | 2005 | 468 | 0.220 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 877 | 0.210 |
Why?
|
| Drug Therapy, Combination | 6 | 2008 | 1136 | 0.210 |
Why?
|
| Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 15 | 0.210 |
Why?
|
| Medical Oncology | 1 | 2025 | 229 | 0.210 |
Why?
|
| Fever | 2 | 2000 | 308 | 0.210 |
Why?
|
| Respiration, Artificial | 2 | 1998 | 486 | 0.210 |
Why?
|
| Male | 57 | 2025 | 62339 | 0.200 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 200 | 0.200 |
Why?
|
| Streptococcus pneumoniae | 3 | 1997 | 377 | 0.190 |
Why?
|
| Vancomycin | 4 | 2005 | 221 | 0.190 |
Why?
|
| DNA Fingerprinting | 5 | 1996 | 104 | 0.180 |
Why?
|
| Itraconazole | 5 | 2009 | 23 | 0.180 |
Why?
|
| Adult | 39 | 2025 | 30325 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2007 | 529 | 0.170 |
Why?
|
| Endocarditis | 4 | 2013 | 101 | 0.160 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2000 | 24 | 0.160 |
Why?
|
| Pseudomonas Infections | 3 | 1996 | 110 | 0.160 |
Why?
|
| Brain Abscess | 3 | 2013 | 52 | 0.150 |
Why?
|
| Klebsiella pneumoniae | 3 | 2013 | 83 | 0.140 |
Why?
|
| Ventilators, Mechanical | 1 | 1998 | 39 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 5 | 1997 | 1486 | 0.140 |
Why?
|
| Aged | 22 | 2025 | 20158 | 0.140 |
Why?
|
| Fibronectins | 5 | 1993 | 99 | 0.140 |
Why?
|
| Education, Medical | 1 | 2021 | 283 | 0.140 |
Why?
|
| Pneumonia, Bacterial | 1 | 1998 | 76 | 0.140 |
Why?
|
| Female | 32 | 2025 | 68161 | 0.130 |
Why?
|
| Streptomycin | 2 | 1993 | 12 | 0.130 |
Why?
|
| Students, Medical | 1 | 2021 | 338 | 0.130 |
Why?
|
| Bacterial Toxins | 3 | 2006 | 171 | 0.130 |
Why?
|
| Peritonitis | 1 | 1997 | 74 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 2 | 1988 | 132 | 0.130 |
Why?
|
| Microbial Sensitivity Tests | 11 | 2013 | 811 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 1998 | 237 | 0.120 |
Why?
|
| Anti-HIV Agents | 4 | 2009 | 344 | 0.120 |
Why?
|
| Burkholderia cepacia | 1 | 1995 | 1 | 0.120 |
Why?
|
| Streptococcal Infections | 4 | 1997 | 246 | 0.120 |
Why?
|
| Ciprofloxacin | 3 | 2013 | 64 | 0.120 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1995 | 56 | 0.110 |
Why?
|
| Treatment Failure | 2 | 2007 | 333 | 0.110 |
Why?
|
| Legionella | 1 | 1994 | 9 | 0.110 |
Why?
|
| Candidiasis | 3 | 2003 | 108 | 0.110 |
Why?
|
| Opportunistic Infections | 3 | 2002 | 74 | 0.110 |
Why?
|
| Acinetobacter | 1 | 1994 | 9 | 0.110 |
Why?
|
| HIV Seronegativity | 2 | 2007 | 28 | 0.110 |
Why?
|
| Endothelium, Vascular | 3 | 1994 | 460 | 0.110 |
Why?
|
| Interferon-gamma | 2 | 2004 | 521 | 0.110 |
Why?
|
| Tetracycline Resistance | 1 | 1993 | 8 | 0.110 |
Why?
|
| Phenytoin | 1 | 1994 | 57 | 0.100 |
Why?
|
| Dermatomycoses | 1 | 2013 | 16 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2005 | 226 | 0.100 |
Why?
|
| DNA, Bacterial | 7 | 2013 | 484 | 0.100 |
Why?
|
| Drug Repositioning | 1 | 2013 | 29 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 50 | 0.100 |
Why?
|
| Risk Factors | 8 | 2015 | 10512 | 0.100 |
Why?
|
| Voriconazole | 1 | 2013 | 30 | 0.100 |
Why?
|
| Histocytochemistry | 1 | 2013 | 85 | 0.100 |
Why?
|
| Syndrome | 3 | 2005 | 1133 | 0.100 |
Why?
|
| Retrospective Studies | 10 | 2025 | 16928 | 0.100 |
Why?
|
| Psychosurgery | 1 | 2013 | 27 | 0.100 |
Why?
|
| DNA Transposable Elements | 1 | 1993 | 180 | 0.100 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 46 | 0.100 |
Why?
|
| Acinetobacter baumannii | 1 | 2013 | 45 | 0.100 |
Why?
|
| Double-Blind Method | 5 | 2010 | 1573 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 1996 | 144 | 0.100 |
Why?
|
| Sequence Deletion | 2 | 1993 | 511 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 1995 | 277 | 0.090 |
Why?
|
| Pyridones | 1 | 2013 | 135 | 0.090 |
Why?
|
| Microscopy | 1 | 2013 | 121 | 0.090 |
Why?
|
| Bioprosthesis | 1 | 2013 | 111 | 0.090 |
Why?
|
| Triazoles | 1 | 2013 | 129 | 0.090 |
Why?
|
| Rifampin | 3 | 2004 | 117 | 0.090 |
Why?
|
| Diltiazem | 1 | 1991 | 14 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2025 | 3313 | 0.090 |
Why?
|
| Suppuration | 1 | 2011 | 3 | 0.090 |
Why?
|
| Disease Outbreaks | 2 | 1995 | 307 | 0.090 |
Why?
|
| Texas | 6 | 2025 | 3548 | 0.090 |
Why?
|
| Antibodies, Fungal | 1 | 2011 | 13 | 0.090 |
Why?
|
| Vulva | 1 | 2011 | 14 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 302 | 0.090 |
Why?
|
| Escherichia coli Infections | 2 | 2008 | 184 | 0.090 |
Why?
|
| Tuberculosis, Hepatic | 1 | 1991 | 3 | 0.090 |
Why?
|
| Perineum | 1 | 2011 | 49 | 0.090 |
Why?
|
| Mitral Valve | 1 | 2013 | 250 | 0.090 |
Why?
|
| Sulbactam | 1 | 1990 | 6 | 0.090 |
Why?
|
| Liver Abscess | 1 | 1990 | 13 | 0.090 |
Why?
|
| Neoplasms | 1 | 2025 | 2852 | 0.090 |
Why?
|
| Ampicillin | 1 | 1990 | 58 | 0.080 |
Why?
|
| Drug Administration Schedule | 4 | 2008 | 729 | 0.080 |
Why?
|
| Radiography | 3 | 2011 | 750 | 0.080 |
Why?
|
| Genotype | 3 | 2013 | 2600 | 0.080 |
Why?
|
| Clostridium Infections | 1 | 2013 | 242 | 0.080 |
Why?
|
| Nitro Compounds | 2 | 2007 | 23 | 0.080 |
Why?
|
| Drug Hypersensitivity | 1 | 1991 | 97 | 0.080 |
Why?
|
| Case Management | 1 | 2010 | 17 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2010 | 270 | 0.080 |
Why?
|
| Aged, 80 and over | 9 | 2013 | 6594 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2013 | 403 | 0.080 |
Why?
|
| Lipids | 1 | 2013 | 549 | 0.080 |
Why?
|
| Sepsis | 3 | 2006 | 491 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 315 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2008 | 171 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 1992 | 763 | 0.080 |
Why?
|
| Thrombocytopenia | 1 | 1991 | 222 | 0.080 |
Why?
|
| Norfloxacin | 1 | 2008 | 5 | 0.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 428 | 0.070 |
Why?
|
| Bacterial Proteins | 3 | 2006 | 909 | 0.070 |
Why?
|
| Prevotella melaninogenica | 1 | 2008 | 2 | 0.070 |
Why?
|
| Ofloxacin | 1 | 2008 | 30 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 92 | 0.070 |
Why?
|
| Creatinine | 1 | 2010 | 379 | 0.070 |
Why?
|
| Levofloxacin | 1 | 2008 | 47 | 0.070 |
Why?
|
| Treatment Outcome | 9 | 2025 | 12501 | 0.070 |
Why?
|
| Incidence | 5 | 2005 | 3239 | 0.070 |
Why?
|
| Secondary Prevention | 2 | 2006 | 215 | 0.070 |
Why?
|
| Pulmonary Medicine | 1 | 2008 | 30 | 0.070 |
Why?
|
| Recurrence | 4 | 2007 | 1404 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 5 | 2013 | 192 | 0.070 |
Why?
|
| Urology | 1 | 1989 | 84 | 0.070 |
Why?
|
| Chest Pain | 1 | 2008 | 93 | 0.070 |
Why?
|
| Benzoxazines | 1 | 2007 | 24 | 0.070 |
Why?
|
| Neutrophils | 2 | 1995 | 350 | 0.070 |
Why?
|
| Cough | 1 | 2008 | 94 | 0.070 |
Why?
|
| Amoxicillin | 1 | 2008 | 118 | 0.070 |
Why?
|
| Receptors, IgG | 1 | 2007 | 56 | 0.070 |
Why?
|
| Distemper Virus, Canine | 1 | 1986 | 3 | 0.070 |
Why?
|
| Osteitis Deformans | 1 | 1986 | 9 | 0.070 |
Why?
|
| Fatigue | 1 | 2008 | 194 | 0.060 |
Why?
|
| Soft Tissue Infections | 1 | 2008 | 88 | 0.060 |
Why?
|
| Endothelium | 1 | 1986 | 63 | 0.060 |
Why?
|
| Superantigens | 1 | 2006 | 20 | 0.060 |
Why?
|
| Enterotoxins | 1 | 2006 | 76 | 0.060 |
Why?
|
| Arm | 1 | 2006 | 72 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2008 | 304 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 479 | 0.060 |
Why?
|
| Splenic Infarction | 1 | 2005 | 3 | 0.060 |
Why?
|
| Hiccup | 1 | 2005 | 6 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1849 | 0.060 |
Why?
|
| Publishing | 1 | 2007 | 101 | 0.060 |
Why?
|
| Facial Dermatoses | 1 | 2005 | 7 | 0.060 |
Why?
|
| United States | 8 | 2010 | 11253 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 924 | 0.060 |
Why?
|
| Drug Interactions | 3 | 2009 | 239 | 0.060 |
Why?
|
| Bartonella | 2 | 1995 | 10 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2007 | 417 | 0.060 |
Why?
|
| Azoles | 2 | 2003 | 8 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2004 | 232 | 0.060 |
Why?
|
| Edema | 1 | 2006 | 140 | 0.060 |
Why?
|
| Klebsiella Infections | 2 | 1996 | 61 | 0.060 |
Why?
|
| Mycoplasma Infections | 1 | 2004 | 10 | 0.060 |
Why?
|
| Fibrosis | 1 | 2006 | 398 | 0.050 |
Why?
|
| Urinary Tract Infections | 1 | 1989 | 310 | 0.050 |
Why?
|
| Persian Gulf Syndrome | 1 | 2004 | 16 | 0.050 |
Why?
|
| Gentamicins | 1 | 2004 | 83 | 0.050 |
Why?
|
| Streptococcus pyogenes | 2 | 1996 | 80 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 788 | 0.050 |
Why?
|
| Weight Loss | 1 | 2008 | 503 | 0.050 |
Why?
|
| Developing Countries | 1 | 2006 | 298 | 0.050 |
Why?
|
| Intracranial Hypertension | 2 | 2010 | 129 | 0.050 |
Why?
|
| Arthritis, Infectious | 2 | 1996 | 65 | 0.050 |
Why?
|
| Doxycycline | 1 | 2004 | 119 | 0.050 |
Why?
|
| Antibodies, Bacterial | 4 | 1996 | 402 | 0.050 |
Why?
|
| Fungemia | 1 | 2003 | 21 | 0.050 |
Why?
|
| Pain | 1 | 2006 | 428 | 0.050 |
Why?
|
| Viral Load | 1 | 2005 | 398 | 0.050 |
Why?
|
| Ketoconazole | 3 | 1993 | 10 | 0.050 |
Why?
|
| Candida | 1 | 2003 | 79 | 0.050 |
Why?
|
| Mycobacterium Infections | 1 | 2003 | 32 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 261 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2005 | 510 | 0.050 |
Why?
|
| Mycobacterium bovis | 1 | 2003 | 32 | 0.050 |
Why?
|
| Mucormycosis | 1 | 1983 | 31 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 1090 | 0.050 |
Why?
|
| Animals | 9 | 2013 | 33184 | 0.050 |
Why?
|
| Equipment Contamination | 2 | 1995 | 40 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2003 | 105 | 0.050 |
Why?
|
| Palliative Care | 1 | 2025 | 438 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 1983 | 194 | 0.040 |
Why?
|
| Flucytosine | 2 | 2000 | 10 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2008 | 866 | 0.040 |
Why?
|
| Problem-Based Learning | 1 | 2021 | 75 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 1131 | 0.040 |
Why?
|
| Mycobacterium avium Complex | 1 | 2000 | 20 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 92 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 64 | 0.040 |
Why?
|
| Acute Disease | 2 | 2004 | 1065 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2005 | 6125 | 0.040 |
Why?
|
| Child | 7 | 2010 | 25086 | 0.040 |
Why?
|
| Models, Biological | 2 | 2000 | 1370 | 0.040 |
Why?
|
| Adolescent | 6 | 2010 | 19976 | 0.040 |
Why?
|
| Bacterial Typing Techniques | 3 | 1995 | 99 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 246 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 269 | 0.040 |
Why?
|
| Prognosis | 3 | 2005 | 4717 | 0.040 |
Why?
|
| Plasmids | 3 | 1995 | 445 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2004 | 757 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2025 | 1021 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 1994 | 2905 | 0.040 |
Why?
|
| Syphilis | 2 | 1990 | 92 | 0.040 |
Why?
|
| Hospitals, University | 1 | 1998 | 103 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 107 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2001 | 2193 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1994 | 334 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2005 | 5080 | 0.030 |
Why?
|
| Bacterial Adhesion | 2 | 1989 | 101 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2003 | 741 | 0.030 |
Why?
|
| Pharyngitis | 1 | 1997 | 34 | 0.030 |
Why?
|
| Arthritis, Gouty | 1 | 1996 | 7 | 0.030 |
Why?
|
| Base Sequence | 3 | 1995 | 2771 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1996 | 120 | 0.030 |
Why?
|
| Young Adult | 1 | 2010 | 9651 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 768 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1995 | 3601 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 1995 | 42 | 0.030 |
Why?
|
| Alopecia | 1 | 1995 | 40 | 0.030 |
Why?
|
| Drug Contamination | 1 | 1995 | 34 | 0.030 |
Why?
|
| Carrier State | 2 | 1997 | 77 | 0.030 |
Why?
|
| Albuterol | 1 | 1995 | 51 | 0.030 |
Why?
|
| Administration, Oral | 4 | 2006 | 666 | 0.030 |
Why?
|
| Child, Preschool | 6 | 2010 | 14338 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 1994 | 64 | 0.030 |
Why?
|
| Bacteremia | 2 | 1996 | 420 | 0.030 |
Why?
|
| Vitamin D | 1 | 1995 | 175 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2003 | 4937 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 30 | 0.030 |
Why?
|
| Galactose | 1 | 2013 | 53 | 0.030 |
Why?
|
| Phagocytosis | 3 | 1995 | 191 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2013 | 42 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 2 | 1996 | 65 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1993 | 104 | 0.030 |
Why?
|
| Empyema, Subdural | 1 | 1992 | 7 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 110 | 0.020 |
Why?
|
| Veterans | 1 | 2004 | 1741 | 0.020 |
Why?
|
| Spinal Cord Diseases | 1 | 1992 | 31 | 0.020 |
Why?
|
| Serotyping | 1 | 1992 | 171 | 0.020 |
Why?
|
| Antigens, Fungal | 2 | 2007 | 34 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1995 | 237 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 2 | 2004 | 95 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 292 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2001 | 1365 | 0.020 |
Why?
|
| Mupirocin | 1 | 1991 | 20 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1993 | 334 | 0.020 |
Why?
|
| Minocycline | 1 | 1991 | 42 | 0.020 |
Why?
|
| Haemophilus influenzae | 2 | 1990 | 135 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 297 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 783 | 0.020 |
Why?
|
| Iron | 1 | 2013 | 296 | 0.020 |
Why?
|
| Nasopharynx | 1 | 1990 | 86 | 0.020 |
Why?
|
| Gas Gangrene | 1 | 1990 | 6 | 0.020 |
Why?
|
| Haemophilus Infections | 2 | 1988 | 97 | 0.020 |
Why?
|
| Clostridium | 1 | 1990 | 17 | 0.020 |
Why?
|
| Dysentery, Bacillary | 1 | 1990 | 11 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 1990 | 76 | 0.020 |
Why?
|
| Shigella flexneri | 1 | 1990 | 16 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1990 | 59 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 2 | 2003 | 281 | 0.020 |
Why?
|
| Bacteria | 1 | 1993 | 502 | 0.020 |
Why?
|
| Paralysis | 1 | 1989 | 30 | 0.020 |
Why?
|
| Osteomyelitis | 2 | 1994 | 207 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 1990 | 76 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 1992 | 276 | 0.020 |
Why?
|
| Cattle | 2 | 1989 | 537 | 0.020 |
Why?
|
| Hindlimb | 1 | 1989 | 75 | 0.020 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2009 | 17 | 0.020 |
Why?
|
| Muscles | 1 | 1989 | 224 | 0.020 |
Why?
|
| Joint Prosthesis | 1 | 1989 | 17 | 0.020 |
Why?
|
| Urodynamics | 1 | 1989 | 36 | 0.020 |
Why?
|
| Seizures | 1 | 1994 | 847 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 1991 | 263 | 0.020 |
Why?
|
| Cephalosporins | 1 | 1989 | 136 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 1988 | 53 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1988 | 56 | 0.020 |
Why?
|
| Diphtheria Toxoid | 1 | 1988 | 6 | 0.020 |
Why?
|
| Time Factors | 4 | 2009 | 6098 | 0.020 |
Why?
|
| Haemophilus Vaccines | 1 | 1988 | 32 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 21 | 0.020 |
Why?
|
| Hospitals, County | 1 | 2008 | 22 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 1988 | 103 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 1987 | 7 | 0.020 |
Why?
|
| Mycophenolic Acid | 1 | 2008 | 57 | 0.020 |
Why?
|
| Biopsy | 2 | 2008 | 1236 | 0.020 |
Why?
|
| Debridement | 1 | 2008 | 79 | 0.020 |
Why?
|
| Thoracic Wall | 1 | 2008 | 40 | 0.020 |
Why?
|
| Alkynes | 1 | 2007 | 28 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2008 | 99 | 0.020 |
Why?
|
| Staphylococcus | 1 | 1987 | 67 | 0.020 |
Why?
|
| Spinal Diseases | 1 | 1987 | 43 | 0.020 |
Why?
|
| Optic Neuritis | 1 | 1987 | 33 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2007 | 72 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1988 | 822 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2007 | 104 | 0.020 |
Why?
|
| Polysaccharides | 1 | 1988 | 140 | 0.020 |
Why?
|
| Mediastinitis | 2 | 2000 | 16 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 1987 | 123 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2006 | 92 | 0.020 |
Why?
|
| Patient Compliance | 2 | 2004 | 458 | 0.020 |
Why?
|
| Leukocidins | 1 | 2006 | 38 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1987 | 118 | 0.020 |
Why?
|
| Exotoxins | 1 | 2006 | 45 | 0.020 |
Why?
|
| Infant | 4 | 2008 | 12761 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2006 | 46 | 0.020 |
Why?
|
| Penicillins | 3 | 1996 | 153 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1990 | 936 | 0.020 |
Why?
|
| Haplotypes | 1 | 2007 | 528 | 0.010 |
Why?
|
| Vancomycin Resistance | 1 | 2005 | 21 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 1988 | 395 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2006 | 203 | 0.010 |
Why?
|
| Mycoplasma | 1 | 2004 | 4 | 0.010 |
Why?
|
| Photosensitivity Disorders | 1 | 2004 | 10 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 405 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1991 | 916 | 0.010 |
Why?
|
| Mice | 3 | 2006 | 17629 | 0.010 |
Why?
|
| Nausea | 1 | 2004 | 78 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2754 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2004 | 129 | 0.010 |
Why?
|
| DNA Primers | 2 | 1995 | 602 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 1302 | 0.010 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2003 | 1 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2008 | 553 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4311 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 650 | 0.010 |
Why?
|
| Solubility | 1 | 2003 | 120 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 1388 | 0.010 |
Why?
|
| Pregnancy | 2 | 2010 | 7411 | 0.010 |
Why?
|
| Virulence | 2 | 1996 | 264 | 0.010 |
Why?
|
| Probiotics | 1 | 2005 | 222 | 0.010 |
Why?
|
| Hepatitis | 1 | 2003 | 55 | 0.010 |
Why?
|
| Blood Bactericidal Activity | 2 | 1995 | 18 | 0.010 |
Why?
|
| Joint Diseases | 2 | 1994 | 32 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 949 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2003 | 179 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 2775 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1293 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2003 | 395 | 0.010 |
Why?
|
| Health Planning Guidelines | 1 | 2000 | 33 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2036 | 0.010 |
Why?
|
| Vaccination | 1 | 2005 | 1004 | 0.010 |
Why?
|
| Spinal Puncture | 1 | 2000 | 50 | 0.010 |
Why?
|
| Pericarditis | 1 | 2000 | 44 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 5947 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 2000 | 94 | 0.010 |
Why?
|
| Arthritis | 1 | 2000 | 83 | 0.010 |
Why?
|
| San Francisco | 1 | 1999 | 18 | 0.010 |
Why?
|
| Georgia | 1 | 1999 | 41 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1097 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2030 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 2088 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2003 | 507 | 0.010 |
Why?
|
| Demography | 1 | 1999 | 238 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 529 | 0.010 |
Why?
|
| Pharynx | 1 | 1997 | 64 | 0.010 |
Why?
|
| Klebsiella | 1 | 1996 | 10 | 0.010 |
Why?
|
| O Antigens | 1 | 1996 | 11 | 0.010 |
Why?
|
| Immunotoxins | 1 | 1996 | 21 | 0.010 |
Why?
|
| Aztreonam | 1 | 1996 | 5 | 0.010 |
Why?
|
| Nafcillin | 1 | 1996 | 13 | 0.010 |
Why?
|
| Monobactams | 1 | 1996 | 6 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3261 | 0.010 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1996 | 4 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2000 | 393 | 0.010 |
Why?
|
| Enzymes | 1 | 1996 | 43 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1996 | 70 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1995 | 9 | 0.010 |
Why?
|
| Bartonella Infections | 1 | 1995 | 7 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1995 | 51 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1997 | 898 | 0.010 |
Why?
|
| Calcitriol | 1 | 1995 | 62 | 0.010 |
Why?
|
| Complement Activation | 1 | 1995 | 49 | 0.010 |
Why?
|
| Cats | 1 | 1995 | 113 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1995 | 73 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2000 | 541 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1995 | 94 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 8357 | 0.010 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 1994 | 17 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1995 | 268 | 0.010 |
Why?
|
| Rabbits | 1 | 1995 | 613 | 0.010 |
Why?
|
| Pyelonephritis | 1 | 1994 | 29 | 0.010 |
Why?
|
| Staphylococcal Skin Infections | 1 | 1994 | 38 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 519 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 354 | 0.010 |
Why?
|
| Vitronectin | 1 | 1993 | 4 | 0.010 |
Why?
|
| Codon | 1 | 1993 | 96 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1997 | 1488 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1995 | 410 | 0.010 |
Why?
|
| Patient Selection | 1 | 1997 | 707 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 252 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1993 | 144 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1993 | 280 | 0.010 |
Why?
|
| Abscess | 1 | 1994 | 138 | 0.010 |
Why?
|
| Epidural Space | 1 | 1992 | 13 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1993 | 216 | 0.010 |
Why?
|
| Rhinoscleroma | 1 | 1992 | 4 | 0.010 |
Why?
|
| Tetracyclines | 1 | 1992 | 19 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 1992 | 58 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 223 | 0.010 |
Why?
|
| Point Mutation | 1 | 1993 | 336 | 0.010 |
Why?
|
| Otitis Externa | 1 | 1992 | 4 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 587 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 1994 | 341 | 0.010 |
Why?
|
| Empyema, Pleural | 1 | 1992 | 25 | 0.010 |
Why?
|
| Empyema | 1 | 1992 | 24 | 0.010 |
Why?
|
| Purpura | 1 | 1992 | 25 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1996 | 1179 | 0.010 |
Why?
|
| Knee Joint | 1 | 1992 | 163 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1991 | 110 | 0.010 |
Why?
|
| Phylogeny | 1 | 1993 | 719 | 0.010 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 1992 | 87 | 0.010 |
Why?
|
| Syphilis Serodiagnosis | 1 | 1990 | 13 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1992 | 196 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1990 | 20 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1992 | 106 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1992 | 82 | 0.010 |
Why?
|
| Neurosyphilis | 1 | 1990 | 15 | 0.010 |
Why?
|
| Leukocytes | 1 | 1992 | 203 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 278 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1993 | 308 | 0.010 |
Why?
|
| Cardiomyopathy, Alcoholic | 1 | 1990 | 4 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1990 | 362 | 0.010 |
Why?
|
| Infection Control | 1 | 1991 | 156 | 0.010 |
Why?
|
| Saliva | 1 | 1990 | 129 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 2951 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 307 | 0.000 |
Why?
|
| Hip Prosthesis | 1 | 1989 | 10 | 0.000 |
Why?
|
| Alleles | 1 | 1993 | 1612 | 0.000 |
Why?
|
| Knee Prosthesis | 1 | 1989 | 16 | 0.000 |
Why?
|
| Shoulder Joint | 1 | 1989 | 31 | 0.000 |
Why?
|
| Opsonin Proteins | 1 | 1988 | 19 | 0.000 |
Why?
|
| Organ Size | 1 | 1989 | 436 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1989 | 310 | 0.000 |
Why?
|
| Coagulase | 1 | 1987 | 22 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1990 | 254 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 415 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1989 | 1597 | 0.000 |
Why?
|
| Reoperation | 1 | 1989 | 818 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 987 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1990 | 976 | 0.000 |
Why?
|
| Lung | 1 | 1989 | 1522 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1990 | 1355 | 0.000 |
Why?
|
| Protein Binding | 1 | 1983 | 1662 | 0.000 |
Why?
|